GlassScriptPhysician profile
Parth N Patel
NPI 1881153724
$2,589.86
in general payments reported to CMS, 2019-2025
16 companies · $1,390 in 2025
The $1,390 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $173 · 2024: $1,027 · 2025: $1,390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,945 · Travel and Lodging: $645.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,944.74 |
| Travel and Lodging | $645.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,145.34 | 2023-2025 | Intellis Adaptivestim, Synchromedii, Inceptiv |
| Boston Scientific Corporation | $352.39 | 2024-2025 | Wavewriter Alpha Prime 16, Intracept |
| Vertos Medical, INC. | $193.28 | 2024 | Mild Device Kit |
| Collegium Pharmaceutical, INC. | $141.86 | 2024-2025 | Belbuca |
| Abiomed | $139.49 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $134.88 | 2024-2025 | |
| Globus Medical, INC. | $117.85 | 2025 | Senza, Vyrsa V1 |
| Averitas Pharma INC. | $83.91 | 2024-2025 | Qutenza |
| Nevro Corp. | $80.93 | 2024 | Senza |
| Abbvie INC. | $44.24 | 2025 | |
| Electronic Waveform Lab, INC. | $37.41 | 2025 | |
| Painteq LLC | $28.92 | 2024 | Painteq |
| International Rehabilitative Sciences, INC | $28.66 | 2024-2025 | Rs 4i Plus Sequential Stimulator |
| Biogen, INC. | $25.28 | 2025 | Skyclarys |
| Fidia Pharma USA INC. | $18.61 | 2025 | Triluron |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $16.81 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Parth Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.